Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Pfizer is conducting a review for its Celebrex arthritis brand, now at J. Walter Thompson in New York, in addition to the three brands that are leaving Deutsch, sources said.
WPP Group’s JWT won Celebrex in July 2001, when the client shifted the $70 million account from Leo Burnett in Chicago. The shift came after a review for another arthritis drug, Bextra, in which JWT was a finalist. Interpublic Group’s Deutsch in New York won duties for that drug.
JWT
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in